These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10949726)

  • 1. Polymorphonuclear leukocyte myeloperoxidase levels in patients with Behçet's disease.
    Accardo-Palumbo A; Triolo G; Carbone MC; Ferrante A; Ciccia F; Giardina E; Triolo G
    Clin Exp Rheumatol; 2000; 18(4):495-8. PubMed ID: 10949726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of endothelial cell E-selectin expression by sera from patients with active Behçet's disease: moderate correlation with anti-endothelial cell antibodies and serum myeloperoxidase levels.
    Triolo G; Accardo-Palumbo A; Triolo G; Carbone MC; Ferrante A; Giardina E
    Clin Immunol; 1999 Jun; 91(3):330-7. PubMed ID: 10370379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidases and oxygenases in regulation of neutrophil redox pathways in Behçet's disease patients.
    Melikoglu MA; Kacar C; Cort A; Yucel G; Aslan M
    J Enzyme Inhib Med Chem; 2012 Feb; 27(1):12-7. PubMed ID: 21699462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of hyperchemotaxis in Behçet's disease.
    Takeuchi A; Kobayashi K; Mori M; Mizushima Y
    J Rheumatol; 1981; 8(1):40-4. PubMed ID: 7218257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative enzymes of polymorphonuclear leucocytes and plasma fibrinogen, ceruloplasmin, and copper levels in Behçet's disease.
    Doğan P; Tanrikulu G; Soyuer U; Köse K
    Clin Biochem; 1994 Oct; 27(5):413-8. PubMed ID: 7867220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphonuclear leukocyte elastase levels in patients with Behçet's disease.
    Değer O; Orem A; Akyol N; Bahadir S; Yildirmis S
    Clin Chim Acta; 1995 May; 236(2):129-34. PubMed ID: 7554279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
    Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
    Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-phagocytic beta-glucuronidase release in Behçet's disease.
    Takeuchi A; Kobayashi K; Mori M; Hashimoto A
    Clin Exp Rheumatol; 1986; 4(1):3-7. PubMed ID: 3698358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil and lymphocyte responses to oral Streptococcus in Adamantiades-Behçet's disease.
    Kurauchi T; Yokota K; Matsuo T; Fujinami Y; Isogai E; Isogai H; Ohtsuki H; Oguma K
    FEMS Immunol Med Microbiol; 2005 Feb; 43(2):125-31. PubMed ID: 15681141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro Candidacidal effect of polymorphonuclear neutrophils of Behçet's patients with or without ocular involvement.
    Tekeli A; Tekeli O; Ozdemir O
    APMIS; 2001 Feb; 109(2):108-12. PubMed ID: 11398991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behçet's disease heterogeneity: cytokine production and oxidative burst of phagocytes are altered in patients with severe manifestations.
    Perazzio SF; Soeiro-Pereira PV; de Souza AW; Condino-Neto A; Andrade LE
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S85-95. PubMed ID: 26394190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behçet's disease and streptococcal infection.
    Namba K; Ueno T; Okita M
    Jpn J Ophthalmol; 1986; 30(4):385-401. PubMed ID: 3586405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arachidonic acid metabolites and colchicine in Behçet's disease (BD).
    Gürer MA; Keskin N; Gülekon A; Karel L; Aksakal B; Baysal V
    Prostaglandins Leukot Essent Fatty Acids; 1991 Aug; 43(4):257-9. PubMed ID: 1946553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Types of ocular attacks and lysosomal enzymes in Behçet's disease.
    Namba K; Masuda K
    Jpn J Ophthalmol; 1984; 28(1):80-8. PubMed ID: 6086997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil CD64 expression in Behçet's disease.
    Ureten K; Ertenli I; Oztürk MA; Kiraz S; Onat AM; Tuncer M; Okur H; Akdogan A; Apras S; Calgüneri M
    J Rheumatol; 2005 May; 32(5):849-52. PubMed ID: 15868620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study of antiendothelial cell antibodies in Behcet's disease].
    Zheng WJ; Zhao Y; Tang FL; Dong Y
    Zhonghua Nei Ke Za Zhi; 2005 Dec; 44(12):910-3. PubMed ID: 16409728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a protease responsible for truncated actin increase in neutrophils of patients with Behçet's disease.
    Yamashita S; Suzuki A; Yanagita T; Hirohata S; Toyoshima S
    Biol Pharm Bull; 2001 Feb; 24(2):119-22. PubMed ID: 11217076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities of T-cell subsets in Behçet's syndrome.
    Lim SD; Haw CR; Kim NI; Fusaro RM
    Arch Dermatol; 1983 Apr; 119(4):307-10. PubMed ID: 6220679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma coagulation and fibrinolysis parameters in patients with vascular Behçet's disease, and analysis of the multimeric structure of von Willebrand factor (vWF)].
    Kagawa H; Okubo S
    Ryumachi; 1993 Oct; 33(5):416-23. PubMed ID: 8256164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.